HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Georgia D Tomaras Selected Research

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)

1/2017Immunogenicity of a novel Clade B HIV-1 vaccine combination: Results of phase 1 randomized placebo controlled trial of an HIV-1 GM-CSF-expressing DNA prime with a modified vaccinia Ankara vaccine boost in healthy HIV-1 uninfected adults.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Georgia D Tomaras Research Topics

Disease

113Infections
10/2023 - 01/2007
15HIV Infections (HIV Infection)
12/2022 - 02/2007
14Vaccinia
01/2023 - 03/2011
12Acquired Immunodeficiency Syndrome (AIDS)
12/2023 - 12/2005
9Viremia
12/2023 - 01/2005
6Malaria
01/2024 - 01/2018
6Human Influenza (Influenza)
01/2023 - 07/2009
6Persistent Infection
01/2020 - 01/2010
5Communicable Diseases (Infectious Diseases)
04/2021 - 10/2007
5Virus Diseases (Viral Diseases)
01/2020 - 11/2013
3Pain (Aches)
05/2024 - 10/2021
3COVID-19
10/2023 - 10/2021
3Vesicular Stomatitis
01/2023 - 09/2015
3Typhoid Fever (Typhoid)
10/2021 - 01/2019
2Erythema
05/2024 - 01/2024
2Headache (Headaches)
05/2024 - 10/2021
2Disease Progression
01/2020 - 08/2014
2Hypersensitivity (Allergy)
11/2019 - 10/2007
1Myalgia
05/2024
1Fatigue
05/2024
1Anaphylaxis (Anaphylactic Shock)
03/2024
1Neoplasms (Cancer)
07/2023
1Chickenpox
12/2022
1Pneumonia (Pneumonitis)
01/2021
1Parasitemia
01/2021
1Parasitic Diseases (Parasitic Disease)
01/2021
1Dizziness (Lightheadedness)
01/2018
1Back Pain (Backache)
01/2018
1Hypoxia (Hypoxemia)
01/2018
1Abdominal Pain (Pain, Abdominal)
01/2018
1Neonatal herpes
10/2017
1Blindness (Hysterical Blindness)
10/2017

Drug/Important Bio-Agent (IBA)

81VaccinesIBA
05/2024 - 02/2007
54AntibodiesIBA
10/2023 - 01/2008
27Immunoglobulin G (IgG)IBA
01/2022 - 12/2008
26Proteins (Proteins, Gene)FDA Link
12/2022 - 08/2009
19AIDS VaccinesIBA
07/2023 - 02/2007
19DNA (Deoxyribonucleic Acid)IBA
01/2023 - 03/2011
16Immunoglobulin A (IgA)IBA
11/2019 - 04/2012
14Broadly Neutralizing AntibodiesIBA
10/2023 - 09/2010
14AntigensIBA
01/2020 - 10/2011
13Neutralizing AntibodiesIBA
12/2022 - 01/2010
12EpitopesIBA
10/2023 - 01/2008
10Monoclonal AntibodiesIBA
01/2024 - 04/2010
8Glycoproteins (Glycoprotein)IBA
01/2018 - 05/2008
6env Gene ProductsIBA
01/2022 - 08/2011
6GP 140IBA
01/2020 - 11/2011
6Antiviral Agents (Antivirals)IBA
10/2017 - 11/2011
5A-Form DNA (A-DNA)IBA
01/2022 - 11/2013
4RNA (Ribonucleic Acid)IBA
12/2023 - 01/2005
3Influenza Vaccines (Influenza Vaccine)FDA Link
01/2023 - 08/2009
3DNA VaccinesIBA
01/2023 - 01/2016
3Polysaccharides (Glycans)IBA
01/2022 - 01/2019
3Peptides (Polypeptides)IBA
01/2020 - 01/2017
3MF59 oil emulsionIBA
01/2018 - 02/2015
3Hemagglutinins (Hemagglutinin)IBA
01/2014 - 01/2011
21- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
08/2021 - 01/2021
2Lipid NanoparticlesIBA
04/2021 - 12/2020
2NucleosidesIBA
04/2021 - 12/2020
2Messenger RNA (mRNA)IBA
04/2021 - 12/2020
2aluminum sulfate (alum)IBA
01/2021 - 02/2015
2Fc Receptors (Fc Receptor)IBA
01/2021 - 09/2014
2Recombinant ProteinsIBA
04/2020 - 01/2007
2Immunoglobulin M (IgM)IBA
12/2017 - 12/2008
2Amino AcidsFDA Link
01/2014 - 09/2011
2Immunoglobulins (Immunoglobulin)IBA
01/2014 - 01/2014
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
03/2024
1B-Lymphocyte Epitopes (B-Cell Epitope)IBA
01/2023
1N-acetyltalosaminuronic acid (NAT)IBA
01/2023
1gag Gene Products (gag Protein)IBA
12/2022
1Carrier Proteins (Binding Protein)IBA
10/2021
1Malaria VaccinesIBA
08/2021
1Adenosine Diphosphate (ADP)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Adenosine Monophosphate (AMP)IBA
01/2021
1Conjugate VaccinesIBA
01/2021
1Combined VaccinesIBA
10/2020
1ImmunosorbentsIBA
01/2020
1EnzymesIBA
01/2020
1CD40 Ligand (CD40L)IBA
01/2020
1MucinsIBA
01/2020
1retanefIBA
01/2020
1IgG Receptors (Fc gamma RI)IBA
11/2019
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
01/2019
1Mechanistic Target of Rapamycin Complex 1IBA
01/2019
1Anti-Retroviral Agents (Antiretroviral Agents)IBA
11/2018
1AerosolsIBA
10/2018
1AluminumIBA
01/2018
1InflammasomesIBA
01/2018
1AIDSVAXIBA
01/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2018
1Vaccine AdjuvantsIBA
01/2018
1MVA vaccineIBA
12/2017
1Interleukin-12 (IL 12)IBA
11/2017

Therapy/Procedure

5Therapeutics
01/2022 - 02/2011
2Injections
01/2024 - 01/2019
2Art Therapy
11/2018 - 01/2017
1Intravenous Injections
10/2021
1Microspheres (Microsphere)
01/2021
1Intramuscular Injections
01/2018